[{"address1": "82 Richmond Street East", "city": "Toronto", "state": "ON", "zip": "M5C 1P1", "country": "Canada", "phone": "888-846-3171", "website": "https://www.pharmather.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia and procedural sedation. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; as well as holds a patent and know-how license agreement with The Queen's University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology. The company was incorporated in 2019 and is headquartered in Toronto, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Fabio  Chianelli", "age": 46, "title": "Founder, Chairman & CEO", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 253940, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Carmelo  Marrelli ACIS, B.Comm., C.A., C.P.A., CGA, CPA", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 56551, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Todd", "age": 66, "title": "Corporate Secretary", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0, "open": 0.145, "dayLow": 0.145, "dayHigh": 0.145, "regularMarketPreviousClose": 0.0, "regularMarketOpen": 0.145, "regularMarketDayLow": 0.145, "regularMarketDayHigh": 0.145, "payoutRatio": 0.0, "beta": 3.351, "volume": 13250, "regularMarketVolume": 13250, "averageVolume": 226401, "averageVolume10days": 180710, "averageDailyVolume10Day": 180710, "bid": 0.1401, "ask": 0.145, "bidSize": 0, "askSize": 0, "marketCap": 12835661, "fiftyTwoWeekLow": 0.123, "fiftyTwoWeekHigh": 0.32, "fiftyDayAverage": 0.15344, "twoHundredDayAverage": 0.16577, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": "NaN", "currency": "USD", "tradeable": false, "enterpriseValue": 11246644, "profitMargins": 0.0, "floatShares": 71944755, "sharesOutstanding": 88519104, "heldPercentInsiders": 0.18679, "heldPercentInstitutions": 0.00056, "impliedSharesOutstanding": 88521800, "bookValue": 0.018, "priceToBook": 8.055555, "lastFiscalYearEnd": 1717113600, "nextFiscalYearEnd": 1748649600, "mostRecentQuarter": 1732924800, "netIncomeToCommon": -1471197, "trailingEps": -0.04, "enterpriseToEbitda": -7.774, "52WeekChange": -0.08227849, "SandP52WeekChange": 0.1861316, "quoteType": "EQUITY", "currentPrice": 0.145, "recommendationKey": "none", "totalCash": 1553213, "totalCashPerShare": 0.018, "ebitda": -1446696, "totalDebt": 0, "quickRatio": 7.074, "currentRatio": 7.074, "returnOnAssets": -0.33602002, "returnOnEquity": -0.63767, "freeCashflow": -1223539, "operatingCashflow": -1700472, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "PHRRF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "shortName": "PharmaTher Holdings Ltd.", "longName": "PharmaTher Holdings Ltd.", "marketState": "CLOSED", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "esgPopulated": false, "gmtOffSetMilliseconds": -18000000, "market": "us_market", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.145, "regularMarketTime": 1740168000, "corporateActions": [], "exchange": "OQB", "messageBoardId": "finmb_671235862", "cryptoTradeable": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1610116200000, "regularMarketChange": 0.0, "regularMarketDayRange": "0.145 - 0.145", "fullExchangeName": "OTC Markets OTCQB", "averageDailyVolume3Month": 226401, "fiftyTwoWeekLowChange": 0.021999992, "fiftyTwoWeekLowChangePercent": 0.17886172, "fiftyTwoWeekRange": "0.123 - 0.32", "fiftyTwoWeekHighChange": -0.175, "fiftyTwoWeekHighChangePercent": -0.546875, "fiftyTwoWeekChangePercent": -8.227849, "earningsTimestampStart": 1666349940, "earningsTimestampEnd": 1666349940, "epsTrailingTwelveMonths": -0.04, "fiftyDayAverageChange": -0.008440003, "fiftyDayAverageChangePercent": -0.055005234, "twoHundredDayAverageChange": -0.020769998, "twoHundredDayAverageChangePercent": -0.12529407, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Newscope Capital Corporation", "nameChangeDate": "2025-02-21", "displayName": "PharmaTher", "trailingPegRatio": null, "__fetch_time": "2025-02-22"}]